Evidence map›Paper›PMID 7493906›Full record

ArticleJapanese journal of cancer research : Gann1995

Restoration of the cellular senescence program and repression of telomerase by human chromosome 3.

H Ohmura, H Tahara, M Suzuki, T Ide, M Shimizu, M A Yoshida, E Tahara, J W Shay, J C Barrett, M Oshimura

Open access · bronzeAbstract read
In one paragraph

Article in Japanese journal of cancer research : Gann, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 126 citations in OpenAlex.

  1. Modeling specific aneuploidies: from karyotype manipulations to biological insights.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2023
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

H OhmuraDepartment of Molecular and Cell Genetics, School of Life Sciences, Faculty of Medicine, Tottori University.
H Tahara
M Suzuki
T Ide
M Shimizu
M A Yoshida
E Tahara
J W Shay
J C Barrett
M Oshimura
Tottori University · JPHiroshima University · JPNational Institute of Biological Sciences, Beijing · CNThe University of Texas Southwestern Medical Center · USTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomeres, at the end of chromosomes, shorten with each cell division, resulting in cellular senescence. Tumor cells, unlike normal somatic cells, express a telomerase that maintains the telomere length. Deletion of a gene(s) on chromosome 3 is common in human renal cell carcinoma (RCC) and reintroduction of a normal chromosome 3 into an RCC immortal cell line restored the program of cellular senescence. The loss of indefinite growth potential was associated with the loss of telomerase activity and shortening of telomeres in the RCC cells with a normal chromosome 3. However, microcell hybrids that escaped from senescence and microcell hybrids with an introduced chromosome 7 or 11 maintained telomere lengths and telomerase activity similar to those of the parental RCC23. Thus, restoration of the cellular senescence program by chromosome 3 is associated with repression of telomerase function in RCC cells.

Indexed as

Cellular SenescenceChromosomes, Human, Pair 3Base SequenceCarcinoma, Renal CellDNA PrimersHumansHybrid CellsMolecular Sequence DataTelomeraseTelomereTumor Cells, CulturedDNA PrimersTelomerase

Identifiers

PMID7493906
PMCPMC5920601
OpenAlexW2078220509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.